Pharma
Moderna and Merck’s positive preliminary cancer vaccine results could signal a ‘new era’ of cancer treatment, expert says
The companies say the treatment slowed melanoma recurrence and spread in the trial.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
Tech
Health systems warn of phishing scams using Epic’s MyChart name and logo
The company said the scams don’t reflect any security concerns with the patient portal.
Tech
Hospitals are making large investments in surgical centers capable of high-intensity care
Allina Health will soon open a new $1 billion surgical center focused on complex procedures.
Pharma
Novo and Lilly race to bring next-generation GLP-1s to market
The drugmakers are looking for ways to make the medicines more effective, and to expand their reach beyond weight loss and diabetes.
Tech
Oracle Health launches AI-powered patient portal
The company is looking to compete with Epic, the largest EHR vendor in the US.
Tech
Healthcare marketers are adjusting to shifting expectations
Ogilvy Health CEO discusses the evolving world of healthcare advertising
Tech
The benefits and hidden costs of AI scribes
They may also be contributing to rising medical costs and could lead to higher insurance premiums, experts say.
Retail Pharmacies
The government is forcing PBMs to be more transparent, but will reforms make a difference?
The Consolidated Appropriations Act, passed in February, included several significant reforms for PBMs.
Tech
Clinicians are using AI without guidance. What are the risks?
Unregulated AI use could leave healthcare institutions vulnerable to HIPAA violations, cyberattacks, experts say.
Pharma
Pharma companies home in on GLP-2s and GLP-3s in race to innovate on obesity treatments
Companies are looking at combining several hormone-like molecules to boost results.